Lundbeck Fights $125M Pay-For-Delay Fine In EU
Danish pharmaceutical company H. Lundbeck A/S has appealed a $125.6 million European Commission fine over allegations that it violated antitrust rules by paying generics makers to keep versions of its antidepressant citalopram off the...To view the full article, register now.
Already a subscriber? Click here to view full article